Peer Review History
| Original SubmissionMay 5, 2020 |
|---|
|
PONE-D-20-09935 Efficacy, tolerability, and safety of an innovative medical device for improving oral accessibility during oral examination in patients with special needs: A multicentric clinical trial PLOS ONE Dear Dr. Anastasio, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 10 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Chun-Pin Lin, Ph. D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3. We note that Figure 1 includes an image of a patient / participant in the study. As per the PLOS ONE policy (http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research) on papers that include identifying, or potentially identifying, information, the individual(s) or parent(s)/guardian(s) must be informed of the terms of the PLOS open-access (CC-BY) license and provide specific permission for publication of these details under the terms of this license. Please download the Consent Form for Publication in a PLOS Journal (http://journals.plos.org/plosone/s/file?id=8ce6/plos-consent-form-english.pdf). The signed consent form should not be submitted with the manuscript, but should be securely filed in the individual's case notes. Please amend the methods section and ethics statement of the manuscript to explicitly state that the patient/participant has provided consent for publication: “The individual in this manuscript has given written informed consent (as outlined in PLOS consent form) to publish these case details”. If you are unable to obtain consent from the subject of the photograph, you will need to remove the figure and any other textual identifying information or case descriptions for this individual. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Important note: This review pertains only to ‘statistical aspects’ of the study and so ‘clinical aspects’ [like medical importance, relevance of the study, ‘clinical significance and implication(s)’ of the whole study, etc.] are to be evaluated [should be assessed] separately/independently. Further please note that any ‘statistical review’ is generally done under the assumption that (such) study specific methodological [as well as execution] issues are perfectly taken care of by the investigator(s). This review is not an exception to that and so does not cover clinical aspects {however, seldom comments are made only if those issues are intimately / scientifically related & intermingle with ‘statistical aspects’ of the study}. COMMENTS: You should have given few details [very brief] of ‘Venham test’ which, I guess, is based on eight ‘pictures’ & measures subject’s dental anxiety {maximum score 8}. As even other tools used are expected to yield data in ‘ordinal’ level of measurement, application of non-parametric test(s) [ex. Wilcoxon’s signed ranks test] was/were desirable anyway and followed here is good. However, please note that ‘Multiple linear regression’ used to identify the factors that are associated with spatula-induced variation in the ‘Total Oral Accessibility Score’ is parametric [whereas ‘logistic regression’ is semi-parametric, completely non-parametric regression is also available but not popular (& so no software available, computations are very cumbersome) and moreover, is not ‘powerful’, however, often the logistic regression is considered by many as non-parametric]. I am sure that the authors are aware of the well-known drawbacks of before-after study which is a single-arm design [a type of Quasi-experimental research, it is alright to conduct ‘single-arm’ (before-after) study when that is the only possibility]. It is very essential to keep those limitations in mind while interpreting results. Also note that a classical/ideal clinical trial/study needs/requires a concurrently handled/treated appropriated selected/chosen control/comparison parallel group/arm [pointed-out in limitations later]. I am not sure if present study be called as ‘crossover’ [line 165 in Methods - Study design section: This prospective multicenter interventional open-label one-way crossover clinical trial] when according to lines 217-220 “The study intervention consisted of two immediately successive oral examinations, first without the spatula and then with the spatula. The temporal order of the two oral examinations was fixed rather than being randomized because the spatula should only be used if there is difficulty obtaining access to the oral cavity”. If the word/term ‘one-way crossover’ clinical trial’ is planted/used here to indicate this phenomenon then it is expected to be clarified that way because the phrase ‘one-way crossover clinical trial’ is new (to most including me). When you use a word ‘crossover’ to describe a clinical trial design, a particular/typical trial design comes to mind which is entirely different than the present one. As per account in lines 219-20 i.e. spatula should only be used if there is difficulty obtaining access to the oral cavity, shows that action later depends on outcome of first. And yet the design is called crossover. Only one variation is known [to/in the literature], called as ‘case-crossover’ design [a 'case window', the period of time during which the person was assumed to be a case, and a 'control window’ otherwise] and if that is what it meant {some similarity}, it should be clarified. If this one is proposed as new variation, please explain it in more details. {There was one paper describing/using ‘wait-listed’ control as cross-over but had given details like consequences on analyses} It is highly appreciable that a measure called ‘Oral Accessibility Score’, which is also the primary endpoint of the study, is/ was newly devised for this study. But note that it is mandatory to study/establish its ‘psychometric properties’ [like validity, reliability] after new development / before use. Same is with the ‘Examiner Satisfaction Scale’ Likert scale which was newly devised for this study. {Note that important properties like validity, reliability incidentally is/are been called ‘psychometric properties’ but have nothing to do with ‘psychology’}. Estimation of sample size required/needed to detect the ability of the spatula to increase 20% from baseline frequency of 20%, is correct [please make the sentence little simple to understand more clearly]. All the tools used also seems appropriately used / alright [except for properties of few]. What is the interpretation of values [parameter estimate, Standard deviation & ‘P’ for each “Factor”] displayed in table-4? Is not this a natural question in anybody’s mind? Will you please explain them little bit? Why divided (what is the purpose of dividing) ‘factor’ into categories [like Age as 0-12, 13-17, 18-64, ≥65]? According to my knowledge, nature [type & level of measurement] even of independent variables (in addition to dependent variable) matters in ‘Multiple linear regression’ [all variables are treated as numerical/continuous so that Sex (female=1, male=2) is different than (male=1, female=2)] . Why ‘Center no.1’ is taken as ‘reference category’? {this info may add to understanding, hopefully}. I guess only in logistic regression (and not in ‘Multiple linear regression’) it is necessary to identify ‘reference category’ [if there are more categories than two for a variable] because ‘odds ratio’ is estimated with reference to that category. If those reported ‘parameter estimate’s [column 2 of table 4] are ‘odds ratios’ {i.e. if binary logistic regression is used} then why not report two categories made of dependent variable (Total Oral Accessibility Score)? Prerogative/claim mentioned in lines 400-402 [that: Consequently, it may be useful in not only dental practice but also for caregivers during toothbrushing, thereby helping to improve the parlous oral health of this population] is not clear. Will you please help me understand how it may be helping to improve the parlous oral health of this population? Pointing-out all possible ‘limitations’ [lines 490-543; particularly highlighting that ‘potential bias could have been avoided by conducting a parallel-arm trial’ and ‘further studies validating this scale are needed’ is highly appreciated. In fact, most of the above review cover these issues only. Except these points, the article is very well drafted and study is excellently executed. Though I do not fully agree with positive features listed [lines 544-550], I can definitely say that this article should be accepted with above minor revisions suggested. Excellent article (though non-randomized), recommending minor revision. Reviewer #2: Introduction In the title it is mentioned the study was conducted among special needs population. However, in the introduction the terms ‘disable’ and ‘disability’ are used. Though there is a debate if the terms special needs and disability are the same or not, it is essential the introduction should only use one term as it may confuse the reader of the context. The term ‘special needs’ is not discussed in the introduction section. It is essential to include the prevalence, the definition, categories and relevant literature on oral access among special needs population in this section. 79 – Prevalence of anxiety among the general population and the special needs for dental procedures should be mentioned. 103-105 – The reference is on elderly population. This is not related with the special needs population 114 -140 - The description about the oral devices is too long. It should be summarised and discussed. Any previous studies done on the Efficiency, tolerability and safety of these equipment to be included Methods 228-229 For the Oral Accessibility score – Has there been a validation study? Is there any evidence the tool is a valid one? 258-260 Has the modified Venham score been validated? Need to mention the evidence. 261 – 267 No clear description on dental surgeon satisfaction score. Need to describe if that is validated or not. Does the dental surgeon give an overall mark out of 10 or does he mark each section safety, duration and quality separately? 275-286 In the statistical analysis - Need to mention how the safety, Tolerability, satisfaction of the surgeon and adverse technical events were analysed How the types of disability were divided into 3 segments (physical, behavioural and intellectual) components. How they were categorised needs to be mentioned. It is clear why the randomisation and blinding were not done with the process of the study. However, it is essential to clearly mention why randomisation and blinding was not possible. Need to mention what were the associated factors assessed clearly in the methods section. 216 – It is stated it consisted of two immediately successive oral examinations. But it seems in some cases the 2nd examination was done later. Therefore, need to correct this statement. Results 359-363/ Table 3 - Adverse events were assessed only after one day of the intervention. In the results section it should be mentioned. Otherwise it will give a false idea to the reader. 354 – Need to explain more on the examiner satisfaction score. Clearly mention the separate scores on the different domains (safety, duration and quality) Discussion 400 - There is no mention about the use of this device by the caregivers in introduction or methods section. Without conducting a trial on the caregivers, it is incorrect to suggest it. 422 – The adverse events were assessed only after one day of the intervention. Therefore, you can’t come to the conclusion that there were no adverse events. If you are mentioning it need to mention they were only assessed only for one day after intervention. 435 – The scoring system is discussed in this section. It needs to be included in the methodology section. Need to mention this is not validated in the limitation section 547 – There were some references about other oral devices. Need to compare this device compared to the other ones in terms of safety, tolerability and efficiency. Need to discuss about the generalisability of the study findings including external validity and applicability Conclusion 558-559 As this was not tested on regular toothbrushing need to remove this component Reviewer #3: 1. The authors used the spatula to get good oral accessibility in the same participants, therefore, it is obviously that using the device could enhance the accessibility. The study did not show the unique availability. The authors did not compare the difference between using other similar devices to get oral accessibility. In this situation, it is not capable to ascertain if using other devices could also get the similar effect. The authors might find the similar device named as mouth rests or mouth stick, which also can enhance the oral accessibility. By the way, for the stick with thermoplastic rubber material on the biting site and polypropylene on the hand holding site, it is easy to handle with no or nearly few trauma for soft tissue or teeth. If there was comparison between different devices, this study could be more convincing. 2. One of the advantage of the spatula is thinner than the other devices, and the adverse events were also few in this study, however, the design of notches is possible to cause the soft tissue damage including lip and gum, especially, in using less than three notches. The retained notch without using might be one of the reasons to cause soft tissue injury. 3. The spatula seems to have the effect of tongue plate. The authors did not highlight this advantage, which is seldom found from the other devices. 4. This study had been made as well preparation, but to present a natural result. As authors’ statement, the spatula is a novel device with patent, however, the authors failed to prove the availability being better than the similar device on the market. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Efficacy, tolerability, and safety of an innovative medical device for improving oral accessibility during oral examination in special-needs patients: A multicentric clinical trial PONE-D-20-09935R1 Dear Dr. Anastasio, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Chun-Pin Lin, Ph. D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: COMMENTS: Since the comments made on earlier draft by me (and hopefully by other respected reviewers also) are attended positively/adequately, I am satisfied and, in my opinion, the manuscript is improved a lot. I recommend acceptance, as I commented earlier that the article is very well drafted and study is excellently executed, and now it has achieved acceptable level of our journal. Please accept. Reviewer #2: All the comments given were addressed by the authors and it seems we can accept this article for publication ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Dr. Sanjeev Sarmukaddam Reviewer #2: Yes: Dr. Mahesh Kumbukage (MBBS, MSc) |
| Formally Accepted |
|
PONE-D-20-09935R1 Efficacy, tolerability, and safety of an innovative medical device for improving oral accessibility during oral examination in special-needs patients: A multicentric clinical trial Dear Dr. Anastasio: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Chun-Pin Lin Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .